Early Access — free while we kick the tires
EdgarHawk

Paz Maestas

CMO & CTO

Officer

Latest: CMO & CTO selling · June 2026

2 filings analyzed · 1 company · Latest 2026-06-11

Never miss a filing from Paz Maestas

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
DXP ENTERPRISES INC DXPE 0 2 Net selling

Activity

June 2026
2026-06-11 DXP ENTERPRISES INC DXPE
medium
Sell
10,000 shares
$1,643,700
Significance 5/10

CMO & CTO Paz Maestas sells 10,000 DXPE shares at $164.37; retains 590,262 shares post-sale

Paz Maestas sold 10,000 shares (10.0K shares) of DXP ENTERPRISES INC (DXPE) at $164.37 on 2026-06-11 for a total value of $1,643,700.00 ($1.6M), reducing holdings from 600,262 to 590,262 shares (a -1.7% reduction). The stock is currently trading at $167.44, approximately -9.0% from its 52-week high of $183.91, though it has appreciated +16.4% over the past 30 days and +28.4% over the past 90 days. Notably, this represents a continuation of selling activity for Maestas at this ticker: his prior sale at DXPE on 2025-08-18 showed negative 90-day returns (-24.5%), consistent with his broader cross-ticker track record where 100.00% of his prior sells were well-timed (higher percentage indicates sells preceding stock declines). The company is trading at a P/E of 29.48 with strong fundamentals: annual revenue growth of +11.9% and latest quarterly revenue of $521,658,000.00 ($521.7M).

August 2025
2025-08-18 DXP ENTERPRISES INC DXPE
low
Sell
5,000 shares
$600,550
Significance 3/10

CMO & CTO sells 5,000 shares of DXPE at $120.11; stock up 22.0% in 30 days

MAESTAS PAZ sold 5,000 shares at $120.11, reducing holdings from 605,737 shares to 600,737 shares—a -0.8% reduction representing a modest, single-transaction disposition. The stock has appreciated substantially in recent weeks (up 22.0% over 30 days and up 38.5% over 90 days) while trading near its 52-week high of $122.29, which provides context for the sale price relative to recent momentum. The company's fundamentals show steady health with $498.7M in latest quarterly revenue, $23.6M net income, and 7.4% annual revenue growth, with a P/E of 22.01 and $1.9B market cap suggesting a mature, moderately valued business. The sale's modest scale relative to total holdings (0.8% reduction) and its execution during a period of strong upward price momentum warrant observation, though the transaction alone is not sufficient to signal material concern or conviction.

Related insiders